-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QD50SXGeRBt5iqGOFZy/BfKSSHQHiQ4avLRfcWWHMxelvCu8+bIyg9wxvCUxpgE2 NNxeQmqJ7q4gvHvfrM3rVQ== 0000906779-08-000004.txt : 20080516 0000906779-08-000004.hdr.sgml : 20080516 20080515211508 ACCESSION NUMBER: 0000906779-08-000004 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080515 FILED AS OF DATE: 20080516 DATE AS OF CHANGE: 20080515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GRUPO CASA SABA SA DE CV CENTRAL INDEX KEY: 0000906779 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12632 FILM NUMBER: 08840188 BUSINESS ADDRESS: STREET 1: FRAY SERVANDO TERESA DE MIER NO. 100 STREET 2: COL CENTRO CITY: MEXICO STATE: O5 ZIP: DF 06080 BUSINESS PHONE: 5252274559 MAIL ADDRESS: STREET 1: PASSO DE LA REFORMA STREET 2: NO 215 450 PISO CITY: MEXICO STATE: O5 ZIP: 11000 FORMER COMPANY: FORMER CONFORMED NAME: HOUSE OF AUTREY GROUP DATE OF NAME CHANGE: 19930614 6-K 1 gcspressmay1508.htm GCS AQUIRES A PHARMACY CHAIN IN BRAZIL Grupo Casa Saba

GRUPO CASA SABA

Grupo Casa Saba Announces the Aquisition of a Pharmacy             Chain in Brazil

Mexico City, Mexico, May 15, 2008. - As part of its growth strategy, Grupo Casa Saba, S.A.B. de C.V. (“Saba”, “GCS”, “the Company” or “the Group”) (BMV and NYSE: SAB), is expanding its operations to Brazil. With today’s signing of the respective documentation, the Group will acquire 100% of the shares of Drogasmil Medicamentos e Perfumaria S.A. (“Drogasmil”). Once certain agreed upon conditions precedent are met, the transaction price will be approximately $185 million Brazilian reals (the equivalent of $115 million dollars based on today’s exchange rate).

Brazil is the most important pharmaceutical market in Latin America, with around US$12 billion in annual sales in 2007. GCS’s entrance into this market demonstrates that it is committed to seeking out opportunities for further growth.

In 2007, Drogasmil’s sales were around $270 million Brazilian reals (the equivalent of $165 million dollars based on today’s exchange rate). Currently, the company operates pharmacies in the states of Río de Janeiro, Sao Paulo and Paraná. With its distribution centers and points-of-sale, Drogasmil is an important actor in the pharmaceutical sector and will be GCS’s platform for growth in this country. This is GCS’s first acquisition outside of Mexico.

About Grupo Casa Saba

Grupo Casa Saba, S.A.B. de C.V. (“Saba”, “GCS”, “the Company” or “the Group”) is one of the leading Mexican distributors of pharmaceutical products, beauty aids, personal care and consumer goods, general merchandise and publications. In 2007, the company had total sales of $25,259 million pesos. The Group is listed on both the Bolsa Mexicana de Valores (Mexican Stock Exchange) and the NYSE.

Contacts:

Grupo Casa Saba                                                          IR Communications
Rodrigo Echagaray, IRO                                               Jesús Martínez Rojas
(52 55) 5284-6672                                                        (52 55) 5644-1247
rechagar@casasaba.com                                            jesus@irandpr.com

Alejandro Sadurni, CFO
asadurni@casasaba.com

-----END PRIVACY-ENHANCED MESSAGE-----